WNT5A–ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3

Up-Regulated Expression of WNT5a Increases Inflammation and Oxidative Stress via PI3K/AKT/NF-κB Signaling in the Granulosa Cells of PCOS Patients

(2015) Yue Zhao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth

(2015) G. Gritsina et al.   MOLECULAR CANCER THERAPEUTICS

The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer

(2014) C.E. Ford et al.   GYNECOLOGIC ONCOLOGY

Inflammation Amplifier, a New Paradigm in Cancer Biology

(2013) T. Atsumi et al.   CANCER RESEARCH

Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells

(2012) Yue Wang et al.   CYTOKINE

Wnt5a activates THP-1 monocytic cells via a β-catenin-independent pathway involving JNK and NF-κB activation

(2012) Jungtae Kim et al.   CYTOKINE

Differential Regulation of the Mouse and Human Wnt5a Alternative Promoters A and B

(2012) Karen S. Katula et al.   DNA AND CELL BIOLOGY

Wnt5a Induces a Tolerogenic Phenotype of Macrophages in Sepsis and Breast Cancer Patients

(2012) C. Bergenfelz et al.   JOURNAL OF IMMUNOLOGY

Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence

(2011) B. G. Bitler et al.   CANCER RESEARCH

Wnt5a as a Predictor in Poor Clinical Outcome of Patients and a Mediator in Chemoresistance of Ovarian Cancer

(2011) Chunjie Peng et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production

(2011) Martina Rauner et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancer

(2010) Christina M. Annunziata et al.   CANCER

Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells

(2010) Yue Wang et al.   CANCER LETTERS

Wnt5a Induces Endothelial Inflammation via  -Catenin-Independent Signaling

(2010) J. Kim et al.   JOURNAL OF IMMUNOLOGY

Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase

(2010) H Yamamoto et al.   ONCOGENE

Requirement of the NF-κB pathway for induction of Wnt-5A by interleukin-1β in condylar chondrocytes of the temporomandibular joint: functional crosstalk between the Wnt-5A and NF-κB signaling pathways

(2010) Xian-Peng Ge et al.   OSTEOARTHRITIS AND CARTILAGE

Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells

(2010) Michiru Nishita et al.   TRENDS IN CELL BIOLOGY

Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors

(2009) Heehyoung Lee et al.   CANCER CELL

Toll-like receptor expression in normal ovary and ovarian tumors

(2009) Mingfu Zhou et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling

(2009) M Enomoto et al.   ONCOGENE

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma

(2009) T M Wright et al.   ONCOGENE

The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma

(2009) M P O’Connell et al.   ONCOGENE

Wnt5A/CaMKII Signaling Contributes to the Inflammatory Response of Macrophages and Is a Target for the Antiinflammatory Action of Activated Protein C and Interleukin-10

(2008) Claudia Pereira et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Wnt5a regulates directional cell migration and cell proliferation via Ror2-mediated noncanonical pathway in mammalian palate development

(2008) F. He et al.   DEVELOPMENT

Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells

(2008) R Chen et al.   ONCOGENE